Equity · Healthcare
AXGN
NASDAQAxoGen (AXGN)
The line runs 49.66 USD on 12 August through 50.62 USD on 9 November, on a scale from 30 to 60. Days the market did not trade hold the previous close, flat.
- Market cap
- 3.0B USD
- Revenue, year to Dec 2025
- 225.2M USD
- EPS, diluted, year to Dec 2025
- −0.34 USD
- 52-week range
- 23 USD – 52 USD
- Avg volume
- 114.7K
as of Nov 9, 2026
Have AxoGen (AXGN) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, AxoGen insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 6 Oct 2025, show no open-market purchase.
Form 4, 90 days to 10 Nov 2026, newest reported trade 2 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Sep 2026 | TYNDALL JOSEPH A.Director | Sell | 3,500 | 174K USD |
Which funds hold AxoGen (AXGN)?
8 of the 45 institutional funds we track reported a AxoGen position for the quarter ended 30 Jun 2026 — a combined 128.5M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Citadel Advisors | Added | 1,360,831 | 62.9M USD | +455.3% |
| Two Sigma Investments | Trimmed | 319,203 | 14.7M USD | −53.2% |
| Marshall Wace | Added | 298,301 | 13.8M USD | +783.8% |
| D. E. Shaw & Co. | Held (±25%) | 277,738 | 12.8M USD | +4.8% |
| Balyasny Asset Management | Trimmed | 253,498 | 11.7M USD | −76.7% |
| Point72 Asset Management | Held (±25%) | 224,618 | 10.4M USD | +11.0% |
| Millennium Management | Trimmed | 27,240 | 1.3M USD | −96.5% |
| AQR Capital Management | Added | 21,217 | 980K USD | +85.8% |
What has been filed or recorded for AxoGen (AXGN)?
The filings we hold for AxoGen, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.04 USD | Revenue $76M |
| 30 Sep 2026 | Financials | Total assets | 550.3M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 496.1M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.03 USD | Revenue $70M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.38 USD | Revenue $61M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.34 USD | Revenue $225M |
| 31 Dec 2025 | Financials | Revenue | 225.2M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −15.7M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.34 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.01 USD | Revenue $60M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.01 USD | Revenue $57M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.08 USD | Revenue $49M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.23 USD | Revenue $187M |
What do people ask about AxoGen (AXGN)?
What did AxoGen shares close at?50.62
AxoGen closed at 50.62 USD on 9 Nov 2026, up 1.44% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is AxoGen’s market cap?3.0B
AxoGen is worth 3.0B USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is AxoGen’s revenue?225.2M
AxoGen reported revenue of 225.2M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have AxoGen insiders bought or sold shares recently?1 sale
In the 90 days to 10 Nov 2026, AxoGen insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 6 Oct 2025, show no open-market purchase. See Insiders
Which funds own AxoGen?8 of 45
8 of the 45 funds we track reported a AxoGen position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Two Sigma Investments and Marshall Wace. See Funds
When did AxoGen last report earnings?0.04
AxoGen last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.04 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings